LRCX HOLD: Maintain full position into defined mechanical triggers; $269 stop and $343.84 upgrade threshold
HOLD at full weight into defined mechanical triggers honors three binding lessons: (a) the 9/18 lesson that structural-bid franchises with these characteristics punish Underweight sizing, (b) the 9/15 lesson that mid-sized trims are alpha noise, and (c) the 9/17 lesson that holding through defined triggers captures the structural-bid reversal alpha. The neutral analyst's 20-25% trim is intellectually tempting but is exactly the cosmetic adjustment the 9/15 lesson warns produces alpha noise rather than alpha signal. A Q3 miss with guide-down and continued receivables deterioration would justify immediate upgrade to Underweight regardless of price action; conversely, a clean beat-and-raise with rising 2027 WFE outlook would justify Trigger A acceleration to Overweight ahead of the $343.84 break.
| Position | Action |
|---|---|
| Current position weight | Maintain full position — do not trim into $320-330 resistance zone |
| Post-Trigger A activation (close >$343.84 on 1.5x volume) | Upgrade to Overweight with full weight |
| $269 break on volume (200 SMA structural confirmation) | Full Underweight or exit regardless of price action |
| Position volatility | Remain at or modestly below typical large-cap tech weight due to beta of 1.86 |
LRCX is the dominant AI picks-and-shovels play with elite fundamentals (65% ROE, 31% net margin, $5B+ FCF) that just printed a technical reversal at the 200 SMA while consensus expects EPS to nearly double, compressing the forward P/E to 26.7x and setting up multiple expansion alongside earnings growth.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 293.08 | bullish |
| 50 SMA | 306.04 | neutral |
| 200 SMA | 268.49 | bullish |
| RSI | 54.57 | neutral |
| MACD | −5.82 | bullish |
| MACD Signal | −7.28 | neutral |
| MACD Histogram | +1.46 | bullish |
| Bollinger Upper | 330.68 | neutral |
| Bollinger Middle | 297.25 | neutral |
| Bollinger Lower | 263.83 | bullish |
| ATR | 15.89 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
LRCX has best-in-class financial metrics that support premium valuation and earnings growth
EV: +5.5% to +10.5% · concedes: 39% drawdown from $438 to $269 is real and painful; Trailing P/E of 54x looks expensive on surface; Beta of 1.86 means elevated volatility; China exposure creates regulatory risk; Higher-for-longer rates limit multiple expansion; Concentration in hyperscaler capex creates demand concentration risk
LRCX is a great company at a terrible entry point, trading at 54x trailing earnings at cyclical peak with a 50 SMA in downtrend and a bearish MACD structure—the risk/reward is asymmetric to the downside.
EV: -$215 to $235 (30%+ downside from current levels) · concedes: LRCX is a great company with best-in-class margins and strong services revenue; Forward P/E of 26.7x is mathematically lower than trailing 54x; Services revenue growth is real; Recession odds did drop from 15% to 8%; The ATR compression from $27.77 to $15.89 does indicate volatility contracting
→ vs conservative: Holding based on backward-looking 31% net margins and 65% ROE ignores receivables up 29% QoQ, the first sign of demand softening while income statement still looks healthy
→ vs conservative: The 39% drawdown from June peak, lower highs since, and receivables spike are already confirmation—the cycle has turned
→ vs conservative: Wait for confirmation of what? Confirmation of overvaluation? The data is already in
→ vs neutral: Committing capital on day 1 of potential reversal (50 SMA reclaim) is premature, not balanced
→ vs neutral: Misreading institutional notes as endorsements at current $310 levels; BofA and Eisman are playing mean reversion off September lows near $270, not $310
→ vs neutral: Asymmetric opportunity: trim now, reload at $320-$330, or hard stop at $343.84 gives acceptable outcomes in both directions; wait-and-see leaves money on the table
Support: 306.04 · 297.25 · 269.23 · 263.83 | Resistance: 320.42 · 330.68 · 343.84
LRCX staged a sharp recovery from its September 16 closing low of $269.23 (near the 200 SMA at $268.49) to $310.96 on 2026-09-22, reclaiming the 50 SMA (306.04) for the first time since the June peak collapse from $438.50. The 10 EMA (293.08) is rising sharply and price sits ~16% above the 200 SMA, confirming long-term uptrend integrity. The MACD histogram turned positive (+1.46) for the second consecutive session after bottoming at −19.16 on July 29, signaling an early-stage momentum flip. RSI recovered to 54.57 from deeply oversold territory (31.09 on July 29), offering room to extend before hitting overbought conditions. Bollinger Bands contracted significantly (upper fell from $414 to $330.68; lower narrowed from $275 to $263.83), forming a volatility squeeze that often precedes directional moves. ATR compressed to 15.89 from a peak of $27.77, suggesting stabilizing volatility. Key resistance sits at $320.42 (September 8 high), $330.68 (Bollinger upper band), and ~$343.84 (August swing high). Recommended stop for tactical longs: ~$278 (2× ATR below the 200 SMA cushion). Rating: HOLD.
Market Cap
$389.11B
Share Price (52W High/Low)
$438.50 / $125.02
50-Day Avg
$306.42
200-Day Avg
$267.92
P/E (TTM)
53.99x
Forward P/E
26.69x
PEG Ratio
1.41
P/B Ratio
31.20x
Beta
1.86
Dividend Yield
0.44%
Revenue (TTM)
$23.23B
Gross Profit
$11.73B (50.5% margin)
EBITDA
$8.64B (37.2% margin)
Net Income
$7.27B (31.3% margin)
Operating Margin
37.4%
Profit Margin
31.3%
ROE
65.1%
ROA
22.8%
EPS (TTM)
$5.76
Forward EPS
$11.65
Total Assets (Q2 2026)
$23.53B
Cash & Equivalents (Q2 2026)
$5.58B
Total Debt (Q2 2026)
$3.73B
Net Cash Position
~$1.85B
Stockholders' Equity (Q2 2026)
$12.47B
Working Capital (Q2 2026)
$9.67B
Current Ratio
2.63x
Debt-to-Equity
0.33
Inventory (Q2 2026)
$4.28B
Accounts Receivable (Q2 2026)
$5.34B
FCF (Q2 2026)
$1.27B
Annualized FCF
~$5.1B (TTM: $3.09B)
Buybacks (LTM)
$3.86B
Share Count Reduction
1.69B to 1.25B
Treasury Stock
$31.6B
R&D Spending (Q2 2026)
~$643M
Strengths
Concerns
Lam Research Corporation (LRCX) is a leading semiconductor wafer fabrication equipment supplier with exceptional profitability metrics including 31.3% net margin and 65.1% ROE. The company benefits from AI/HBM-driven demand for etch and deposition equipment, generating ~$5B+ annualized FCF with a strong balance sheet (net cash position, 2.63x current ratio). Aggressive buybacks have reduced share count by 26% over five quarters, supporting EPS growth. The valuation shows P/E compression from 54x trailing to 26.7x forward, implying consensus expects EPS to nearly double. Key risks include elevated cyclical exposure, 1.86 beta volatility, and geopolitical export control concerns.
Macro: Recession odds collapsed to 8% (-7pp w/w) per Polymarket; Fed funds path shows 96% probability of ZERO rate cuts in 2026 (+2.7pp w/w) — firmly in higher-for-longer hold/no-cut posture. Risk-on tone evident with Bitcoin back above $86K and broad equity rallies. Washington–Beijing dialogue improving with 'AI Force' proposal and softer regulatory signals reducing tail risk on China-exposed WFE names. Bank of America issued a 'bold' buy call on chips post-AI sell-off with demand characterized as 'far stronger than slowdown fears imply.'